Navigation Links
New Evidence Published in Muscle and Nerve on Measuring 6-Minute Walk Distance in Duchenne Muscular Dystrophy
Date:8/26/2013

results, performance or achievements to differ significantly from those expressed or implied by these forward-looking statements. Such risks and uncertainties include, among others, those related to the initiation and conduct of clinical trials, availability of data from clinical trials, expectations for regulatory approvals, our scientific approach and general development progress, the availability or commercial potential of our product candidates and other factors discussed in the "Risk Factors" section of the final prospectus for our initial public offering, which is on file with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent PTC's views only as of the date of this release. PTC anticipates that subsequent events and developments will cause its views to change. However, while PTC may elect to update these forward-looking statements at some point in the future, PTC specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing PTC's views as of any date subsequent to the date of this release.


'/>"/>
SOURCE PTC Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy
2. Publication of PrEP Trial Data Provides Clear Evidence that PrEP Works for Men and Women
3. 90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
4. Annai Systems And ThoughtWorks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer
5. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
6. Zynx Health Launches Unrivaled MEDITECH Integration for Evidence-based Care Plans
7. J.D. Power and Associates Reports: Evidence that Relationship Marketing Still Matters in Oncology Pharmaceutical Sales
8. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
9. New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease
10. New Data from Silences Atu027 Anticancer Trial Published at ASCO
11. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Releases of the genetically ... aegypti , , reduced the dengue mosquito population ... by 95%, well below the modelled threshold for ... The journal PLOS Neglected Tropical Diseases published ... engineered mosquitoes. The results showed that in Juazeiro city, ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has ... Analog, Application, End-User & by Region - Global Trends & ... This market is projected to reach about $2.5 Million by ... and rising opportunities in countries such as India ... , and Brazil . In 2013, ...
(Date:7/2/2015)... -- The Green Exchange, Inc., the developer,s of "Loud Cannabis" ... app that connects cannabis growers directly to patients to ... that their service provides the fastest delivery on the ... half a dozen other delivery apps that have popped ... in that it connects growers directly with patients. ...
Breaking Medicine Technology:Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2
... 2011 Stereotaxis, Inc. (NASDAQ: STXS ) today ... conferences during May 2011: The Deutsche Bank ... and Chief Executive Officer of Stereotaxis, is scheduled to present ... at 4:10 p.m. ET. The JMP Securities Annual Research ...
... Pharmasset, Inc. (Nasdaq: VRUS ), a clinical ... novel drugs to treat viral infections, today reported financial ... 31, 2011. Financial ResultsRevenues were ... compared to $0.3 million for the quarter ended March ...
Cached Medicine Technology:Stereotaxis to Present at Upcoming Investor Conferences 2Stereotaxis to Present at Upcoming Investor Conferences 3Pharmasset Reports Fiscal Second Quarter 2011 Financial Results 2Pharmasset Reports Fiscal Second Quarter 2011 Financial Results 3Pharmasset Reports Fiscal Second Quarter 2011 Financial Results 4Pharmasset Reports Fiscal Second Quarter 2011 Financial Results 5
(Date:7/5/2015)... ... July 05, 2015 , ... Doctors at the Swedish ... IMRT/surgery combination may one day change the outlook for people with pleural mesothelioma. Surviving ... , Researchers report that five mesothelioma patients treated with 25Gy of radiation ...
(Date:7/4/2015)... IRVINE, California (PRWEB) , ... July 04, 2015 ... ... has earned the solar industry’s leading recognition of technical sales expertise from the ... Certified PV Technical Sales ProfessionalTM. NABCEP is the most highly respected and well ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer centers ... minimal asbestos exposure. Click here to read the complete story , just posted ... Center, Cedars Sinai Medical Center, and New York University exposed mice with a mutation ...
(Date:7/3/2015)... ... , ... Smoothies are all the rage right now and all you need ... Aurora Natural is proud to introduce a new line of all natural products that ... and minerals! , Aurora is offering a variety of blends and stand-alone items to ...
(Date:7/3/2015)... Abilene, Texas (PRWEB) , ... July 03, 2015 , ... ... published a new article this week that he says will reveal biblical truth and ... article titled “Why Does Your Bible Say Don’t Have Sex”, immediately goes into the ...
Breaking Medicine News(10 mins):Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2
... 20 Nordic Naturals was,recently named the ... of Vitamin and Supplement Users. Receiving two ... and #1 Rated Health Food,Store Brand for ... satisfaction ratings of all brands considered, throughout ...
... for cerebral aneurysms,with coil embolization (blocking of a ... another aneurysm, say neurological surgeons at Jefferson Hospital ... of its kind. , In a paper published ... Neurosurgery, researchers found there was an increased risk ...
... founder,and executive chairman of Aon Corporation, today announced he ... is the world,s largest,insurance and reinsurance intermediary, and a ... transition to a new management team under the,sound leadership ... continued growth and success. After 41 years as CEO ...
... Event is Open to the Public, Providing Access ... and Childhood,Illnesses, WASHINGTON, March 19 Mental ... area will have,an opportunity on Sunday, March 30th, ... in the military and about other serious mental ...
... number of terrestrial sources that yield novel treatments for ... been tapped as a promising resource for discovering new ... Diego, each utilizing mass spectrometry in novel ways, have ... from the sea that could one day treat diseases ...
... Corporation, a leading,international manufacturer, marketer, and supplier of ... its 2007 fourth,quarter and full year financial results., ... Company generated net sales of,$253.7 million, an increase ... in,the fourth quarter of 2006. Excluding the impact ...
Cached Medicine News:Health News:Nordic Naturals Named Top-Rated Supplement Brand in ConsumerLab.com Survey of Vitamin and Supplement Users! 2Health News:Smokers treated for brain aneurysm with coils at higher risk of recurrence 2Health News:Patrick G. Ryan Announces Intention to Retire from Aon 2Health News:Patrick G. Ryan Announces Intention to Retire from Aon 3Health News:NARSAD's 5th Annual 'Mission Possible' Symposium Offers Insight to PTSD and Other Mental Illnesses 2Health News:NARSAD's 5th Annual 'Mission Possible' Symposium Offers Insight to PTSD and Other Mental Illnesses 3Health News:NARSAD's 5th Annual 'Mission Possible' Symposium Offers Insight to PTSD and Other Mental Illnesses 4Health News:Researchers sharpen search for new marine medicines with novel techniques 2Health News:Researchers sharpen search for new marine medicines with novel techniques 3Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 2Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 3Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 4Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 5Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 6Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 7Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 8Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 9Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 10Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 11
... three-level control for monitoring and ... confirm cystic fibrosis. The controls ... Chloridometer, Flame Photometer, Osmometer, Sweat-Chek ... & Schales Titration, Synchron and ...
... designed to validate HDL cholesterol plus other ... This control is compatible with most major ... Synchron and Vitros. HDL values are given ... methods: Dextran Sulfate 50,000 MW. Apolipoprotein A-1 ...
... is intended as a means ... ethanol assay methods. This ready-to-use, ... clinically significant levels of ammonia ... provided for the following instruments: ...
... is intended as a means ... assay methods used for the ... urine samples. This control is ... This control is supplied as ...
Medicine Products: